摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]amino] (2S)-2-(diaminoamino)-4-methylsulfanylbutanoate

中文名称
——
中文别名
——
英文名称
[[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]amino] (2S)-2-(diaminoamino)-4-methylsulfanylbutanoate
英文别名
——
[[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]amino] (2S)-2-(diaminoamino)-4-methylsulfanylbutanoate化学式
CAS
——
化学式
C14H23N9O5S
mdl
——
分子量
429.46
InChiKey
AMZGCPXUYFBBGN-BIMBKFBVSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.5
  • 重原子数:
    29
  • 可旋转键数:
    9
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.57
  • 拓扑面积:
    238
  • 氢给体数:
    6
  • 氢受体数:
    14

文献信息

  • [EN] IMMUNOASSAY OF S-ADENOSYLMETHIONINE USING ANALOGS THEREOF AND PERSONALIZED THERAPEUTICS<br/>[FR] IMMUNOESSAI DE LA S-ADÉNOSYLMÉTHIONINE FAISANT APPEL À DES ANALOGUES DE CETTE DERNIÈRE ET THÉRAPEUTIQUE PERSONNALISÉE
    申请人:HUNAN SKYWORLD BIOTECHNOLOGIES CO
    公开号:WO2014146137A1
    公开(公告)日:2014-09-18
    A method of detecting the presence or absence of a disease in a patient wherein said disease is accompanied by deficient levels of S-adenosylmethionine comprising: identifying a patient that is suspected of having said disease or is at risk of having said disease; obtaining a biological sample from said patient; determining the level of S-adenosylmethionine in said biological sample using an antibody derived from a hapten analog of S-adenosylmethionine; and correlating the level of S-adenosylmethionine in said biological sample with the presence or absence of said disease. The invention also provides methods for meauring SAH which is used to determine the methylation index (ratio of SAM/SAH) in biological fluids which is indicative ofm the health status of an individual.
    一种检测患者是否患有伴随着S-腺苷酸缺乏的疾病的方法,包括:识别疑似患有该疾病或有患病风险的患者;从该患者获取生物样本;使用源自S-腺苷酸类似物的半抗原抗体测定所述生物样本中S-腺苷酸的平;并将所述生物样本中S-腺苷酸的平与所述疾病的存在或不存在相关联。该发明还提供了测量SAH的方法,该方法用于确定生物液体中的甲基化指数(SAM / SAH比率),该指数表明个体的健康状况。
  • Immunoassays of s-adenosylmethionine and methylation index in personalized medicine and health evaluation
    申请人:Hao Xiujuan
    公开号:US10656159B2
    公开(公告)日:2020-05-19
    The invention provides a method of detecting the presence, absence or severity of a disease in a patient wherein said disease is accompanied by decreased level of S-adenosylmethionine, or increased level of S-adenosylhomocysterine, or reduced methylation index comprising: identifying any individual or a patient that is suspected of having said disease or is at risk of having said disease; obtaining a biological sample from said patient; determining the level of SAM in said biological sample using an antibody derived from a hapten analog of SAM, SAH; and correlating the levels of SAM, SAH and MI in said biological sample with the presence, absence, or severity of said disease. The invention also provides methods for determining methylation index in biological fluids which is indicative of the health status of an individual. Additionally, the invention includes colloidal gold test strips and homogenous enzyme immunoassays which are useful for determining S-adenosylmethionine and S-adenosylhomocysteine.
    本发明提供了一种检测患者是否患有疾病或疾病严重程度的方法,其中所述疾病伴有 S-腺苷蛋氨酸平的降低、或 S-腺苷胞嘧啶平的升高、或甲基化指数的降低,该方法包括确定任何疑似患有所述疾病或有可能患有所述疾病的个人或患者;从所述患者处获取生物样本;使用源自 SAMSAH 的单体类似物的抗体确定所述生物样本中的 SAM 平;以及将所述生物样本中的 SAMSAH 和 MI 平与所述疾病的存在、不存在或严重程度相关联。本发明还提供了确定生物液体中甲基化指数的方法,该指数可指示个体的健康状况。此外,本发明还包括胶体试纸和均质酶免疫测定法,可用于测定 S-腺苷蛋氨酸和 S-腺苷高半胱酸。
  • Immunoassay of S-adenosylmethionine in personalized medicine and health or cancer evaluation
    申请人:Hao Xiujuan
    公开号:US10663470B2
    公开(公告)日:2020-05-26
    The invention provides a method of detecting the presence or absence of a disease in a patient wherein said disease is accompanied by deficient levels of S-adenosylmethionine comprising: identifying a patient that is suspected of having said disease or is at risk of having said disease; obtaining a biological sample from said patient; determining the level of S-adenosylmethionine in said biological sample using an antibody derived from a hapten analog of S-adenosylmethionine; and correlating the level of S-adenosylmethionine in said biological sample with the presence, absence, or severity of said disease. The invention also provides methods for measuring SAH which is used to determine the methylation index (ratio of SAM/SAH) in biological fluids which is indicative of the health status of an individual. Additionally, the invention includes test strips which are useful for determining S-adenosylmethionine and S-adenosylhomocysteine.
    本发明提供了一种检测患者是否患有疾病的方法,其中所述疾病伴随着 S-腺苷蛋氨酸平的缺乏,该方法包括确定疑似患有所述疾病或有可能患有所述疾病的患者;从所述患者处获取生物样本;使用源自 S-腺苷蛋氨酸的合酶类似物的抗体确定所述生物样本中 S-腺苷蛋氨酸平;以及将所述生物样本中 S-腺苷蛋氨酸平与所述疾病的存在、不存在或严重程度相关联。本发明还提供了测量 SAH 的方法,SAH 可用于确定生物液体中的甲基化指数(SAM/SAH 的比率),该指数可指示个人的健康状况。此外,本发明还包括用于测定 S-腺苷蛋氨酸和 S-腺苷高半胱酸的试纸。
  • IMMUNOASSAY OF S-ADENOSYLMETHIONINE USING ANALOGS THEREOF AND PERSONALIZED THERAPEUTICS
    申请人:Hunan Skyworld Biotechnologies Co.
    公开号:EP2968386A1
    公开(公告)日:2016-01-20
  • US20140271945A1
    申请人:——
    公开号:US20140271945A1
    公开(公告)日:2014-09-18
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸